TRPM4 and ischemic stroke: Currently, anti-diabetic drugs are tested as adjuvant treatment option in ischemic stroke, such as Glyburide, an inhibitor of the sulfonylurea receptor-1, and transient receptor potential melastatin 4 (SUR1-TRPM4).